Contemporary OB/GYN week in review: abortion, cesarean delivery, and more
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Contemporary OB/GYN week in review: abortion, cesarean delivery, and more
Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, December 18 - Friday, December 22, 2023), and click each link to read and watch anything you may have missed.
1.) Clinical implications of the Kate Cox Texas abortion case
Bhavik Kumar, MD, MPH, family medicine doctor in Houston, Texas, discusses how clinicians in Texas and other states where abortion is restricted can help their patients find their necessary care in light of the Kate Cox abortion case in Texas.
Click here for the full article.
2.) Assessing low-risk cesarean delivery rates: Florida's 4-year study insights
A comprehensive study reveals variations in monitoring low-risk cesarean delivery rates across 5 metrics, emphasizing the significance of timely and accurate assessment from birth certificate data.
Click here for the full article.
3.) Optimizing antenatal corticosteroid timing for preterm birth
A recent study reported the link between antenatal corticosteroid timing and the 5 and a half-year survival and neurological outcomes in preterm children, highlighting the importance of evaluating and optimizing the interval between administration and birth for improved long-term results.
Click here for the full article.
4.) Efficient screening method for myofascial urinary frequency syndrome
A recent study unveiled a novel screening method, utilizing validated questionnaires to accurately identify myofascial urinary frequency syndrome in patients with lower urinary tract symptoms.
Click here for the full article.
5.) Hysterectomy without adnexal surgical procedure raises osteoporosis risk
A recent study reveals that hysterectomy without an adnexal surgical procedure increases the risk of osteoporosis among women aged 40 to 59 years, emphasizing the need for informed patient consultation regarding this potential association.
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
